Advertisement
Advertisement

APVO

APVO logo

Aptevo Therapeutics Inc

4.97
USD
Sponsored
+0.11
+2.26%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

4.74

-0.23
-4.71%

Aptevo Therapeutics Inc Profile

About

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.

Info & Links

CEO

Marvin L. White

Headquarters

2401 4TH AVENUE,SUITE 1050
SEATTLE, WA 98121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

http://www.aptevotherapeutics.com

Auditor

Baker Tilly US, LLP

Share holders

2

Employees

36

Aptevo Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

5.60M

Enterprise Value

-16.02M

Enterprise Value/EBITDA(ttm)

0.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.25

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-260.82%

Return on Invested Capital(ttm)

263.13%

Return on Assets(ttm)

-132.90%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-26.07M

Net Income Available to Common(ttm)

-27.54M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.50

52-Week Change

-96.17%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.18M

Dividend Yield

0.00%

Float4

1.18M

% Held by Insiders

0.08%

% Held by Institutions

8.06%

Balance Sheet

Total Cash(mrq)

21.62M

Total Cash Per Share(mrq)

18.29

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.81%

Quick Ratio(mrq)

3.82%

Book Value Per Share(mrq)

17.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-81.11

Free Cash Flow(ytd)

-25.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement